Lifetime Achievements Awards 2019
The Lifetime Achievement Awards are a heartfelt tribute to the unwavering dedication of sarcoma specialists and patient representatives who have made a lasting impact on the sarcoma community. SPAGN proudly acknowledges and honors their outstanding contributions to sarcoma research and patient advocacy, their passion, perseverance, and unwavering commitment to making a difference. Through their work in research and advocacy, they have brought hope, inspired meaningful change, and helped shape a better future for everyone affected by sarcoma.
As we celebrate the recipients of the 2019 Lifetime Achievement Awards, we recognize their outstanding contributions—offering hope, inspiring change, and helping to shape a brighter future for everyone impacted by sarcoma.
2019 Lifetime Achievement Award Recipients
Roger Wilson, UK
Roger Wilson, CBE, is a pioneering sarcoma patient advocate whose work has had a profound impact on patient engagement, research, and policy. As the founder of Sarcoma UK, co-founder of SPAEN/SPAGN and a leading voice in international advocacy, he has been instrumental in strengthening the role of patient representatives in clinical trials, research initiatives, and healthcare policy discussions. As Honorary President of SPAGN, he has played a vital role in guiding the organization’s mission and impact, further advancing global sarcoma advocacy and patient-driven research.
Jean-Yves Blay, MD, PhD, France
Jean-Yves Blay, MD, PhD, is a world-renowned medical oncologist specializing in sarcomas and rare cancers. As the Director of the Centre Léon Bérard in Lyon and a former President of the European Organisation for Research and Treatment of Cancer (EORTC), he has been a driving force in advancing sarcoma research and clinical care across Europe. His contributions to precision medicine, immunotherapy, and innovative treatment strategies have significantly improved the management and prognosis of sarcoma patients worldwide.
Ian Judson, MD, PhD, UK
Ian Judson, MD, PhD, was a highly respected medical oncologist and sarcoma researcher who played a critical role in the development of modern sarcoma treatments. As a former Head of the Sarcoma Unit at The Royal Marsden Hospital and a key figure in international sarcoma research collaborations, his contributions to clinical trials, particularly in soft tissue sarcomas and gastrointestinal stromal tumors (GIST), have led to groundbreaking therapeutic advancements. His legacy continues to shape the field of sarcoma oncology.
Peter Hohenberger, MD, PhD, Germany
Peter Hohenberger, MD, PhD, is a leading expert in surgical oncology and multidisciplinary sarcoma treatment. As a Professor of Surgical Oncology at the University of Mannheim, he has been at the forefront of developing innovative surgical approaches and multidisciplinary treatment strategies for soft tissue sarcomas and gastrointestinal stromal tumors (GIST). His extensive work in translational research, clinical trials, and international collaborations has significantly enhanced treatment options and outcomes for sarcoma patients.